hsa-miR-1271

ncRNA information

ncRNA name

hsa-miR-1271

Specific or universal ncRNAs

Universal ncRNAs

Class

MicroRNA

Biomarker

No

Biomarker application

Upstream regulatory factors

Not available

Downstream target

Bcl-2

Cancer information

Cancer name

Glioblastoma

Cancer site

Brain, Central Nervous System

Treatment information

Treatment type

Chemotherapy

Drug

Temozolomide

Impact of wild-type ncRNA on chemotherapy resistance

Impact of knockdown of ncRNA on chemotherapy resistance

Up

Impact of overexpression of ncRNA on chemotherapy resistance

Clinical Information

ncRNA differential expression in
cancer patients vs. healthy people

Not available

Number of patients

Not available

Male patients

Not available

Female patients

Not available

Age range and number

Not available

Research information

PMID

Description

Thus, the chemoresistance of GBM cells may be promoted after suppressing miR-1271 through cell survival mediated with Bcl-2.

Tissue resource

clinical samples from patients with glioblastom

human glioblastom cell line A172

Experiment

qRT-PCR,Western blot


Institute

the Affiliated Longhua Central Hospital

American Type Culture Collection

Country

China

USA

Continent

Asia

North American